secwatch.observer — SEC 8-K summary
======================================

Issuer:     Immunovant, Inc. (IMVT)
CIK:        0001764013
Form:       8-K
Filed at:   2022-03-30T23:59:59+00:00
Accession:  0001764013-22-000033
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Immunovant R&D Day presentation filed; details not fully available in text
--------------------------------------------------------------------------

- Immunovant hosted a virtual R&D Day on March 30, 2022; presentation filed as Exhibit 99.1.
- The filed exhibit contains only the title slide; no specific data or updates are extractable from the provided text.
- Investors should refer to the complete presentation for pipeline and clinical trial updates.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1764013/000176401322000033/0001764013-22-000033-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1764013/000176401322000033/imvt-20220330.htm
  HTML page:      https://secwatch.observer/filing/0001764013-22-000033

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer